Previous studies have shown that BRAF inhibition in melanoma cell lines resulted in a decreased secretion of immunosuppressive factors like IL-10, VEGF, and IL-6 and enhanced expression of melanocyte differentiation antigens (MDA) to improve recognition by MDA-specific T cells [33]. This evidence concerns the gene BRAF and melanoma.